AxoGen News and Activities

Presence

AxoGen is a leading company specializing in the development and commercialization of innovative surgical solutions for peripheral nerve injuries. The company provides a range of products aimed at the repair and regeneration of nerve function, serving surgeons and health institutions primarily in the United States.

Avance Nerve Graft
AxoGuard Nerve Connector
AxoGuard Nerve Protector
AxoTouch Two-Point Discriminator

2024 Revenue: Estimated around $150 million

Employees: 300

AxoGen is one of the...

AxoGen is a company listed under the stock ticker AXGN (US).

AxoGen has a direct presence in 2 countries.

They are in:

Healthcare50%
Medical Equipment50%

Executives

View the org chart displaying its 33 main executives

Most searched biographies at AxoGen

Popular executive movements at AxoGen

Nir Naor, Chief Financial Officer, will leave the company on May 12, 2025 (posted on May 8 2025).
Lindsey Hartley who is Vice President, Corporate Controller, will be promoted to Chief Financial Officer on May 12, 2025 (posted on May 8 2025).
Rick Ditto has joined the company as Vice President, Global Health Economics, Reimbursement & Policy (posted on March 25 2025).

Click here to view some more movements at AxoGen

Create your alert
to follow the executive moves at AxoGen.